Amended loan schedule details $9.59M in debt facilities.
Acura Pharmaceuticals updated its borrowing agreements, recognizing $9.594M in additional loans and extending notes through 2026.
View filing at SEC.gov →2 most recent filings and news items mentioning ACUR. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/ACUR/news?limit=20"
Pull ACUR filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayAcura Pharmaceuticals updated its borrowing agreements, recognizing $9.594M in additional loans and extending notes through 2026.
View filing at SEC.gov →Acura Pharmaceuticals updated its loan schedule with Abuse Deterrent Pharma, LLC, increasing the total outstanding principal to approximately $10.7 million as of June 2026. This amendment details specific terms for additional loans ranging from 2022 to 2026.
View filing at SEC.gov →